Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells. [electronic resource]
Producer: 20080508Description: 1076-84 p. digitalISSN:- 0007-0920
- Antineoplastic Combined Chemotherapy Protocols
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Endometrial Neoplasms -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Female
- Humans
- Lapatinib
- Oncogene Protein v-akt -- metabolism
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- administration & dosage
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.